The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director of Suraksha Diagnostic Ltd, has disclosed the acquisition of 8,235 equity shares of the company through open market purchase on 13 August 2025. This acquisition increased his holding from 26,30,531 shares (5.051%) to 26,38,766 shares (5.067%), representing a marginal increase of 0.016% in his stake. The total paid-up capital of the company stands at 5,20,80,758 equity shares of ₹2 each. The disclosure was filed under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011.
This is a minor open-market purchase by a promoter indicating continued confidence in the company. The negligible size of the acquisition (just 8,235 shares) means it is unlikely to have any meaningful impact on stock price or shareholder value, though it does signal promoter optimism at current levels.